Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion type Assertion NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_head.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion description "[60% of transgenic mice that overexpressed both OLIG2 and LMO1 developed pre-T lymphoblastic lymphoma/leukemia with large thymic tumor masses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_provenance.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion evidence source_evidence_literature NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_provenance.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion SIO_000772 16103065 NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_provenance.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion wasDerivedFrom lhgdn-20090331 NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_provenance.
- NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_assertion wasGeneratedBy ECO_0000203 NP190630.RAR5DZHq_-C4PgJMwUTPKuSVETzq0a37t19R8oI-4Q3VA130_provenance.